Alpha Tau Medical Ltd.
DRTS
$2.68
$0.0150.56%
Weiss Ratings | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.92 | |||
Price History | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -6.47% | |||
30-Day Total Return | -26.71% | |||
60-Day Total Return | -12.87% | |||
90-Day Total Return | 20.50% | |||
Year to Date Total Return | -13.71% | |||
1-Year Total Return | -8.39% | |||
2-Year Total Return | -11.13% | |||
3-Year Total Return | -76.84% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -39.36% | |||
52-Week Low % Change | 52.00% | |||
Price | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $4.39 | |||
52-Week Low Price | $1.75 | |||
52-Week Low Price (Date) | Jun 27, 2024 | |||
52-Week High Price (Date) | Jan 27, 2025 | |||
Valuation | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 186.47M | |||
Enterprise Value | 133.82M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.28 | |||
Earnings Per Share Growth | -14.72% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | 2.51 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $2.68 | |||
Enterprise Value/EBITDA (TTM) | -4.93 | |||
Enterprise Value/EBIT | -4.79 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 69.87M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 3 577 4115 | |||
Address | -- | |||
Website | www.alphatau.com | |||
Country | Israel | |||
Year Founded | 2015 | |||
Profitability | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 15.23% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | 15.87% | |||
Balance Sheet | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 71.03M | |||
Cash Per Share (Q) | $1.02 | |||
Total Current Assets (Q) | 75.25M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 74.02M | |||
Current Ratio (Q) | 11.656 | |||
Book Value Per Share (Q) | $1.06 | |||
Total Assets (Q) | 96.05M | |||
Total Current Liabilities (Q) | 6.46M | |||
Total Debt (Q) | 12.56M | |||
Total Liabilities (Q) | 22.03M | |||
Total Common Equity (Q) | 74.02M | |||
Cash Flow | DRTS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||